Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

CFG

Citizens Financial Group Reports Strong Q2 Results

Citizens Financial Group, Inc. has reported strong results for the second quarter of 2025, with net income of $436 million and earnings per share (EPS) of $0.92. This represents a significant increase from the first quarter of 2025, with EPS up by $0.15.

The company saw a 3% sequential growth in net interest income (NII) and a 10% increase in fee income. The positive operating leverage was approximately 5%, reflecting strong revenue performance and disciplined expense management.

Key financial data for the second quarter of 2025 includes a pre-provision net revenue (PPNR) of $718 million, up 16% from the first quarter. The net interest margin (NIM) increased by 5 basis points to 2.95%, and interest-earning assets were up by 1%.

Loans increased by 1% quarter-over-quarter, with growth across the private bank, commercial, and consumer segments. The net charge-offs decreased slightly by 48 basis points, and the allowance for credit losses (ACL) coverage remained strong at 1.59%.

Average deposits also showed a 1% increase quarter-over-quarter, with growth in lower-cost categories. The liquidity profile remained robust, with a spot loan-to-deposit ratio of 79.6% and a strong common equity tier 1 (CET1) ratio of 10.6%.

Comparing the second quarter of 2025 to the first quarter, the company declared a quarterly common stock dividend of $0.42 per share, reflecting confidence in its financial position and performance.

In terms of underlying financial metrics, diluted EPS was $0.92, up from $0.77 in the first quarter. Return on average tangible common equity (ROTCE) and return on average total tangible assets also showed significant improvements.

Following these announcements, the company's shares moved 0.6%, and are now trading at a price of $46.97. If you want to know more, read the company's complete 8-K report here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS